Zobrazeno 1 - 10
of 57
pro vyhledávání: '"Kazuhiro Kitajima"'
Publikováno v:
Annals of Nuclear Medicine. 36:798-803
Since the inline positron emission tomography (PET)/magnetic resonance imaging (MRI) system appeared in clinical, more than a decade has passed. In this article, we have reviewed recently-published articles about PET/MRI. There have been articles abo
Autor:
Kazuhiro Kitajima, Tomoko Higuchi, Yukie Fujimoto, Eri Ishikawa, Hiroyuki Yokoyama, Hisashi Komoto, Yoshie Inao, Koichiro Yamakado, Yasuo Miyoshi
Publikováno v:
European journal of radiology. 158
To investigate the relationship between fluorodeoxyglucose (FDG) uptake (maximum standardised uptake value [SUVmax]) and immune markers (tumour-infiltrating lymphocytes [TILs] and neutrophil-to-lymphocyte ratio [NLR]) and evaluate the potential progn
Autor:
Kazuhiko, Kimura, Kazuhiro, Kitajima, Yusuke, Kawanaka, Hiroyuki, Yokoyama, Hisashi, Komoto, Masayuki, Fujiwara, Yoshitaka, Furukawa, Akihiro, Kanematsu, Shingo, Yamamoto, Hideaki, Miyake, Koichiro, Yamakado
Publikováno v:
International journal of urology : official journal of the Japanese Urological AssociationReferences. 29(9)
The utility ofEighty-fourPretreatment
Autor:
Mitsutaka Nemoto, Atsuko Tanaka, Hayato Kaida, Yuichi Kimura, Takashi Nagaoka, Takahiro Yamada, Kohei Hanaoka, Kazuhiro Kitajima, Tatsuya Tsuchitani, Kazunari Ishii
Publikováno v:
Physics in Medicine & Biology. 67:195013
We propose a method to detect primary and metastatic lesions with Fluorine−18 fluorodeoxyglucose (FDG) accumulation in the lung field, neck, mediastinum, and bony regions on the FDG-PET/CT images. To search for systemic lesions, various anatomical
Autor:
Kazuhiro, Kitajima, Yusuke, Kawanaka, Hisashi, Komoto, Toshiyuki, Minami, Takashi, Yokoi, Kozo, Kuribayashi, Takashi, Kijima, Akifumi, Nakamura, Masaki, Hashimoto, Nobuyuki, Kondo, Seiki, Hasegawa, Koichiro, Yamakado
Publikováno v:
Hellenic journal of nuclear medicine. 24(3)
To compare three fluorine-18-fluorodeoxyglucose positron emission tomography (Forty NSCLC patients underwentThe number of complete metabolic response (CMR)/partial metabolic response (PMR)/stable metabolic disease (SMD)/progressive metabolic disease
Publikováno v:
Radiological Physics and Technology. 12:343-350
We aimed to evaluate the influence of noise and object size on segmentation accuracy of fluorodeoxyglucose positron emission tomography (FDG-PET) imaging. The scanned data of spherical phantoms were used. For the gradient method, 40% maximum standard
Autor:
Hiroo Yoshikawa, Kazuhiro Kitajima, Masanaka Takeda, Koichiro Yamakado, Kazuo Abe, Mana Ohigashi, Hidenori Koyama, Keiko Osugi
Publikováno v:
Medicine
This study aimed to evaluated the clinical impact of adding [11C] Pittsburgh compound-B (11C-PiB) PET for clinical diagnosis of mild cognitive impairment (MCI) to Alzheimer's disease (AD) dementia. Twenty six (mean age 78.5 ± 5.18 years, 21 females)
Autor:
Takao Ohtsuka, Kazuhiro Kitajima, Masatoyo Nakajo, Hiromitsu Daisaki, Hiroto Miwa, Takaaki Arigami, Akira Toriihara, Takashi Yoshiura, Akira Nakamura
Publikováno v:
Medicine
Recent breakthrough results from immune checkpoint inhibitors (ICIs) have paved the way to a new era of cancer immunotherapy, and have thus led to a paradigm shift of cancer treatment. In particular, inhibition of the antiprogrammed death-1 (PD-1)/pr
Autor:
Hiroshi Doi, Kazuhiro Kitajima, Shingo Kanemura, Yoshiki Negi, Kozo Kuribayashi, Takashi Kijima, Eriko Fujimoto, Takashi Nakano, Koji Mikami
Publikováno v:
Expert Review of Anticancer Therapy. 17:865-872
Mesothelioma of peritoneal origin has wider variation in treatment outcomes than mesothelioma of pleural origin, likely because peritoneal mesothelioma comprises borderline malignant variants and aggressive malignant peritoneal mesothelioma (MPeM). T
Autor:
Hiroshi, Doi, Masayuki, Fujiwara, Kazuhiro, Kitajima, Masao, Tanooka, Tomonori, Terada, Kazuma, Noguchi, Reiichi, Ishikura, Norihiko, Kamikonya, Koichiro, Yamakado
Publikováno v:
Nagoya Journal of Medical Science
Concomitant intra-arterial infusion chemoradiotherapy (IA-CRT) has been used to treat locally advanced maxillary sinus squamous cell carcinoma (MSSCC) with positive outcomes. However, an optimal predictive prognostic factor for MSSCC treated with IA-